| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.evexialifecare.com | |
| Market Cap | 96.62 Cr. | |
| Enterprise Value(EV) | 106.49 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.02 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 88.48 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 35.68 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 1.20 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 1.30 | Calculated using Price: 1.56 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 61.93 Cr. | 619,334,330 Shares |
| FaceValue | 1 | |
| Company Profile | ||
| It is an established name involved in the manufacturing industrial oil as well as edible oil. The array of products produced and supplied by the company includes. The company take extreme care in meeting the various requirements of the clients while supplying the diverse range of products in the market. | ||
| 1 Day |
|
-4.88% |
| 1 Week |
|
-4.29% |
| 1 Month |
|
-20.0% |
| 3 Month |
|
+0.65% |
| 6 Month |
|
-13.33% |
| 1 Year |
|
-38.58% |
| 2 Year |
|
-88.94% |
| 5 Year |
|
-1.27% |
| 10 Year |
|
+246.67% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 1.37 | 0.30 | 0.25 | 1.37 | 0.73 | 2.35 | 5.01 | 1.79 | 1.19 | |
| Return on Capital Employed (%) | 0.15 | 0.27 | 0.44 | 1.86 | 1.05 | 3.16 | 6.81 | 2.46 | 2.89 | |
| Return on Assets (%) | 0.12 | 0.16 | 0.18 | 0.54 | 0.23 | 0.72 | 1.55 | 0.70 | 0.64 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 54 | 66 | 65 | 66 | 73 | 75 | 78 | 80 | 80 | 81 | |
| Non Curr. Liab. | 6 | 4 | 10 | 115 | 120 | 101 | 85 | 10 | 16 | 20 | |
| Curr. Liab. | 0 | 5 | 37 | 38 | 15 | 48 | 61 | 52 | 31 | 50 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Equity & Liab. | 60 | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 151 | |
| Non Curr. Assets | 58 | 71 | 50 | 58 | 136 | 136 | 95 | 33 | 43 | 44 | |
| Curr. Assets | 3 | 3 | 61 | 161 | 72 | 88 | 129 | 109 | 83 | 106 | |
| Misc. Exp. not W/O | 1 | 0 | 0 | 1 | |||||||
| Total Assets | 60 | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 151 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 1 | 1 | 34 | 178 | 74 | 105 | 100 | 107 | 76 | 65 | |
| Other Income | 1 | 0 | 1 | 0 | 1 | 3 | 12 | 74 | 0 | 2 | |
| Total Income | 1 | 1 | 34 | 178 | 75 | 109 | 112 | 181 | 76 | 66 | |
| Total Expenditure | -1 | -1 | -34 | -176 | -74 | -106 | -107 | -179 | -73 | -63 | |
| PBIDT | 0 | 0 | 0 | 1 | 1 | 3 | 5 | 2 | 2 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -2 | |
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 1 | 1 | 1 | |
| Minority Interest | 0 | ||||||||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 1 | 1 | 1 | |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -3 | 4 | 11 | -116 | -12 | 0 | -3 | 2 | -6 | |
| Cash Fr. Inv. | -2 | 0 | 2 | 1 | -6 | 0 | 1 | -2 | 8 | |
| Cash Fr. Finan. | 5 | -4 | -12 | 113 | 18 | 0 | 2 | 1 | -1 | |
| Net Change | 0 | 1 | 1 | -2 | 0 | 0 | 0 | 0 | 1 | |
| Cash & Cash Eqvt | 0 | 1 | 2 | -1 | 1 | 1 | 0 | 1 | 2 |
|
Wed, 29 Mar 2023
Closure of Trading Window This is to inform you that pursuant to the provisions of SEBI (Prohibition of insider trading) Regulations 2015 read with the Companys Code of Conduct to Regulate Monitor and Report Trading by designated persons & their immediate relatives (including all insiders) the Trading Window in respect of dealings in the Equity Shares of the Company will remain closed for all the designated persons of the Company & their immediate relatives with effect from Saturday April 1 2023 till the conclusion of 48 hours after the declaration of the Audited Financial Results of the Company for the fourth quarter and year ended on 31stMarch 2023. The Date of Board Meeting for approval of Audited financial results for the Fourth quarter and year ended on 31stMarch 2023 shall be intimated in due course.Kindly take the same on your record. |
|
Tue, 28 Mar 2023
Board Meeting Outcome for Outcome Of Independent Directors' Meeting In Compliance with Section 149(8) read with Schedule IV of the Companies Act 2013 and Regulations 25(3) of the SEBI LODR Regulations 2015 a separate Board Meeting of Independent Directors of the Company was held today i.e. Tuesday March 28 2023to transact the following business: 1. Reviewed the performance of Non-Independent Directors and the Board as a whole. 2. Reviewed the performance of the Chairperson of the company taking into account the views of Executive Directors and Non-Executive Directors; 3. Assessed the quality quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties.The Meeting Commenced at 4.10 PM and Concluded at 5.00 PM. |
|
Thu, 23 Mar 2023
Board Meeting Intimation for Separate Board Meeting Of Independent Directors Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2023 inter alia to consider and approve This is to inform you under Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Section 173 and schedule IV of The Companies Act 2013 notice is hereby given that the separate meeting of Independent Directors of the Company will be held on Tuesday March 28 2023 to consider and approve the following agenda/ business-1- To review the performance of non-independent directors and the Board as a Whole.2- To review the performance of the Chairperson of the company taking into account the views of executive directors and non-executive directors;3- To assess the quality quantity and timeliness of flow of information between the company management and the Board that is necessary for the Board to effectively and reasonably perform their duties.4- Any other business with the permission of chair. |
| Wed, 29 Mar 2023 |
Close Crossing Last Week Low
|
Closing Below Previous Low
|
Close Below Last Week Low
|
High Decrease in 1 Month
|
High Decrease in 1 Year
|
Equities
M.F.
Sectors